UMU logo

Expert in genomics of human immune disorders recruited as new Director of NCMM

Janna Aitiolehteen KirsiTuura July2018Congratulations from MIMS to Janna Saarela to her apointment as new Director of our partner institute in Norway!
[2018-10-12] The University of Oslo has recruited Dr Janna Saarela, Research Director of Institute for Molecular Medicine Finland (FIMM), the Finnish node of the Nordic EMBL Partnership, as the new Director of Centre for Molecular Medicine Norway (NCMM).

"We congratulate our partner institute in Oslo to the appointment of an excellent scientist and competent leader. We look forward to work closely with Janna Saarela and her leadership team through the Nordic EMBL Partnership", commented MIMS Director Oliver Billker the good news from the NCMM.

Dr Saarela is currently head of the FIMM Technology Centre and an adjunct Professor in Medical Molecular Genetics at the University of Helsinki. Her research group at FIMM concentrates on the genomics of immune disorders, especially autoimmunity and immune dysregulation. She also has an MD from the University of Oulu, Finland.

The appointment follows the departure of Professor Kjetil Taskén, who left to take up a new role as Director of the Institute for Cancer Research at Oslo University Hospital in June 2018. Dr Saarela will officially join NCMM in January 2019 as first female director within the EMBL Nordic Partnership for Molecular Medicine.

Read the press release from University of Oslo and NCMM

More information about Janna Saarela on the website of the Institute for Molecular Medicine Finland (FIMM)

picture: Kirsi Tuura

Emmanuelle Charpentier:
MIMS is characterized by
ECharpentier about MIMS 2015 1

Emmanuelle Charpentier, Alumna at MIMS, now Director of the Max Planck Unit for the Science of Pathogens and Director of the Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Berlin, Germany.

Link to the Emmanuelle Charpentier Lab

footer all slides 2014-02-06


Copyright © 2017 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.